HRSA Tells Federal Court it Still Stands by its 340B Patient Definition in Closely Watched Case

Genesis
HRSA says it stands by its patient definition in Genesis' federal lawsuit seeking a far broader definition.
The U.S. Health Resources and Services Administration (HRSA) still stands by its 340B program patient definition, the agency said in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Do 340B Lump Sum Payments Underscore Need for More Transparency or Are They Unrelated?

Peter Pitts
Peter Pitts, president of the Center for Medicine in the Public Interest, says the recently released 340B Medicare lump sum payments underscore the need for more 340B program transparency.
A recently proposed list of planned Medicare payments for individual 340B hospitals is seen as ammunition to some 340B critics. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Amid Historic Financial Challenges, 340B Proposed Payments Will ‘Make a Difference’ for Some Hospitals’ Budgets, Says Rating Official

Fitch Ratings webinar
A Fitch Ratings webinar on the not-for-profit hospital sector discussed the financial implications of the proposed $9 billion lump sum Medicare payment to make up for five years of illegal 340B cuts.
As the not-for-profit hospital sector slowly emerges from its worst financial year in recent history, some of those organizations’ bottom [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Broad Support Emerges for Adding Duplicate Discount Modifiers to Medicaid Cards

CMS duplicate discounts
340B stakeholders broadly support adding identifiers to Medicaid drug beneficiaries’ cards to held avoid duplicate 340B discounts, comments on a CMS proposed rule show.
A federal proposal to require the addition of new identifiers to Medicaid drug beneficiaries’ cards to avoid duplicate 340B discounts [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Sends Previously Audited 340B Hospital a Second Follow-up Compliance Letter

HRSA headquarters
The Health Resources and Services Administration announced that the Office of Pharmacy Affairs will hold a June 11 webinar on the ADR final rule.
A hospital that the U.S. Health Resources and Services Administration audited for 340B program compliance and then was one of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

CMS’s 340B Hospital Repayment Plan Leaves Medicare Advantage Cuts Untouched

Attorney Kyle Vasquez
Attorney Kyle Vasquez says many clients feel they are entitled to a remedy for underpayments from Medicare Advantage plans stemming from CMS' July 7 proposed rule.
The recently proposed Medicare fee-for-service lump sum payments to 340B hospitals to make up for a nearly five-year unlawful rate [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Recertification for Hospitals Starts Aug. 14

HRSA hospital recertification.
HRSA announced this year's 340B eligibility recertification period for hospitals will start Aug. 14 and end Sept. 11.
This year’s 340B eligibility recertification period for hospitals will start Aug. 14 and end Sept. 11, the U.S. Health Resources [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Amgen, Vertex, and AstraZeneca Post 340B Refund and Replenishment Public Notices

Aranesp
Aranesp is among the drugs listed on HRSA's latest manufacturer's notice posted on behalf of Amgen.
The U.S. Health Resources and Services Administration (HRSA) this week published notices from drug makers Amgen and Vertex about refunds [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Report Publisher and CEO to Providers: New 340B Reporting Requirements are Inevitable

Tim Walz
Minnesota became the first state to impose 340B reporting requirements after Gov. Tim Walz (D) signed legislation in late May.
Health care providers almost certainly will have to accept new 340B reporting requirements in order to get unfettered access to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Generic Drugmaker Amring Providing Refunds for 340B Overcharges

Generic drug manufacturer Amring Pharmaceuticals is giving 340B covered entities refunds for overcharges on 14 products between the first quarter [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live